Ocular Oncology News

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, highlights the important takeaways from International Symposium on Pediatric Neuro-Oncology.

PHILADELPHIA — In this video, Michael Fisher, MD, discusses the results of a natural history study he presented at the International Symposium on Pediatric Neuro-Oncology.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Jill Hopkins, MD, of Aura Biosciences discusses a phase 3 program in ocular oncology.

WAILEA, Hawaii — The world of melanoma has changed a lot in recent years and more change is yet to come, according to a speaker at Hawaiian Eye 2024.

The top Healio ocular oncology-related articles in 2023 explored telemedicine’s growing promise and barriers, as well as risk features for malignant melanoma transformation in the eye.

Aura Biosciences announced that it has received an agreement from the FDA under a special protocol assessment for the design of a phase 3 trial assessing belzupacap sarotalocan, according to a press release.

SAN FRANCISCO — Telemedicine has the potential to drive ocular oncology forward, but there are barriers that must be addressed first, according to a speaker here.

In this Healio Video Perspective from the Retina Society meeting, Carol Shields, MD, describes an interesting case she saw in her office.

In this Healio Video Perspective, Carol Shields, MD, discusses data investigating Fitzpatrick skin type and uveal melanoma presented at the Retina Society meeting.